Chapter 11: Systemic Lupus Erythematosus Flashcards
Systemic Lupus Erythematosus (SLE)
chronic multisystem inflammatory disorder
-characterized by an autoimmune anti body production that results in an inflammation of the connective tissue in various organs or systems in the body
Pathophysiology
the immune system is composed of specialized cells that destroy invading organisms by phagocytosis and antibody and lymphocyte production; when foreign organisms or antigen enters the body, it is consumed by macrophages and then passed on to lymphokines, which present to the T and B lymphocytes; The B lymphocytes are activated, resulting in a production of increased number of circulating antibodies that target their specific antigen, the antigen-antibody complex either promotes destruction of the antigen or activates the normal inactive proteins in the complement system
>in SLE, the body fails to recognize its own proteins
Clinical Manifestations result from what?
inflammation of the multiple organ systems, especially joints, skin, kidneys, nervous system, and serous membranes
Risks With SLE
- when SLE complicates pregnancy, there is an increased risk of spontaneous abortion (SAB), PROM, PTL, preterm birth, stillbirth, and neonatal death
- maternal autoantibodies may cross the placenta and form immune complexes with fetal autoantigens, promoting fetal tissue destruction
- autoantibodies may initiate injury to fetal cardiac tissue, resulting in conduction disturbances that may be temporary or permanent
Management
-immunosuppression of lupus flare with corticosteroid therapy, non-steroidal anti-inflammatory drugs, antimalarial agents, azathioprine, and careful fetal surveillance
>if disease flares during pregnancy, treatment must be implemented ASAP
>patient’s health is deemed FIRST PRIORITY
>offer support and remain alert for early indicators of SLE exacerbation
-educate family about plan of care, NEED for close surveillance, and effective family planning after birth
SLE Exacerbation S/S
elicited on the patients history and physical examination, and a blood sample obtained for serological evaluation
- rise in the anti-dsDNA antibody titer and a decrease in complement
- onset of edema and hypertension can be indicative of active SLE-associated nephritis